SOPH NASDAQ
SOPHiA GENETICS S.A.
1W: -5.2%
1M: +4.0%
3M: +51.4%
YTD: +68.5%
1Y: +137.8%
3Y: +237.8%
5Y: -59.6%
$7.87
+0.26 (+3.42%)
Weekly Expected Move ±9.1%
$6
$7
$8
$9
$9
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Bullish
75
Insider+$0.1M
Congress—
ETF Holdings—
Key Statistics
Market Cap$660.3M
52W Range3.1-8.98
Volume243,544
Avg Volume346,749
Beta0.98
Dividend—
Analyst Ratings
Company Info
CEORoss Muken
Employees415
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date2021-07-23
Websitesophiagenetics.com
La Piece 12
Rolle, VD 1180
CH
Rolle, VD 1180
CH
41 21 694 10 60
About SOPHiA GENETICS S.A.
SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.
Latest News
When Unusual Volume Isn't Noise: 3 Small-Caps Sending Signals
SOPHiA GENETICS (SOPH) Q2 2026 Earnings Call Transcript
At a glance: stocks gapping up premarket
Tempus AI Stock Before Q2 Earnings Release: To Buy, Hold or Sell?
Sophia Genetics, Ormat Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| HIBBS KATHY L | S-Sale | 6,250 | $8.13 | 2026-09-08 |
| Xu Zhenyu | S-Sale | 10,000 | $8.91 | 2026-08-27 |
| Menu Philippe | S-Sale | 5,000 | $8.68 | 2026-08-25 |
| HIBBS KATHY L | S-Sale | 6,250 | $8.68 | 2026-08-25 |
| Verma Abhimanyu | S-Sale | 5,000 | $8.80 | 2026-08-24 |